Abnormal Involuntary Movement Scale (AIMS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- No Dyskinesia0–1
- Mild to Moderate Dyskinesia2–13
- Severe Dyskinesia14–28
The Abnormal Involuntary Movement Scale (AIMS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include facial muscles. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Measures involuntary movements of tardive dyskinesia (TD) in patients receiving neuroleptic medications
Clinical Indication
The Abnormal Involuntary Movement Scale (AIMS) is indicated for bedside clinical practice to support Measures involuntary movements of tardive dyskinesia (TD) in patients receiving neuroleptic medications. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.
Sum of items 1-7 (involuntary movements), items 8-10 assess global severity, incapacitation, and awareness
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| facial_muscles | integer | Yes | Facial muscles and facial expression |
| lips_perioral | integer | Yes | Lips and perioral area |
| jaw | integer | Yes | Jaw |
| tongue | integer | Yes | Tongue |
| upper_extremities | integer | Yes | Upper extremities (arms, wrists, hands, fingers) |
| lower_extremities | integer | Yes | Lower extremities (legs, knees, ankles, feet) |
| trunk_movements | integer | Yes | Trunk movements (neck, shoulders, hips) |
| global_severity | integer | Yes | Global severity of abnormal movements |
| incapacitation | integer | Yes | Incapacitation due to abnormal movements |
| patient_awareness | integer | Yes | Patient's awareness of abnormal movements |
| current_problems_teeth | string | Yes | Current problems with teeth/dentures |
| dental_problems_interfere | string | Yes | Do dental problems interfere with movements? |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | No Dyskinesia | Absent or questionable movements |
| 2–13 | Mild to Moderate Dyskinesia | Presence of tardive dyskinesia |
| 14–28 | Severe Dyskinesia | Significant tardive dyskinesia |
Evidence-Based References (EBM)
- Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; 1976.
- National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Psychopharmacology Research Branch, NIMH. 1976.